Status:
UNKNOWN
the Role of plin5 in the Development of Nonalcoholic Fatty Liver Disease.
Lead Sponsor:
Xijing Hospital
Conditions:
Non-alcoholic Fatty Liver Disease
Eligibility:
All Genders
18-70 years
Brief Summary
To further clarify the role of sequence polymorphism in patatin-like phospholipid domain containing protein 3 in the development of nonalcoholic fatty liver disease.
Detailed Description
A sequence polymorphism in patatin-like phospholipid domain containing protein 3 is significantly associated with nonalcoholic fatty liver disease, but its mechanism underlying this association remain...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- The diagnosis of simple fatty liver disease was confirmed by clinical presentation, ultrasound, and without long-term drinking history, viral hepatitis, medication history, obesity (BMI≥30), type 2 diabetes and other metabolic diseases.
- Exclusion criteria:
- With long-term drinking history, viral hepatitis, medication history, obesity (BMI≥30), type 2 diabetes and other metabolic diseases.
Exclusion
Key Trial Info
Start Date :
December 1 2016
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 27 2025
Estimated Enrollment :
240 Patients enrolled
Trial Details
Trial ID
NCT04104282
Start Date
December 1 2016
End Date
December 27 2025
Last Update
September 19 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Department of Ultrasonic Medicine, The Xijing Hospital of Fourth Military Medical University
Xi'an, Shaanxi, China, 710032